SCHEMBL8091846

SCHEMBL8091846

COc1ccccc1N1CCN(CCOc2ccc(-c3cn4ccccc4n3)cc2)CC1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.91
DRD3 P35462 11/20 0.91
HTR1A P08908 4/20 0.72
HTR7 P34969 3/20 0.72
HRH3 Q9Y5N1 1/20 0.62
DRD4 P21917 1/20 0.60
ADRA1D P25100 1/20 0.60
ADRA1A P35348 1/20 0.60
ADRA1B P35368 1/20 0.60
KCNH2 Q12809 1/20 0.59
NPC1 O15118 3/20 0.58
PKM P14618 3/20 0.58
RAB9A P51151 3/20 0.58
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
EPHX2 P34913 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086599 0.95 DRD3 (1.00) DRD2DRD3HTR1AHTR7HRH3
SCHEMBL8086583 0.94 DRD2 (1.00) DRD2DRD3HTR1AHTR7HRH3
SCHEMBL8091832 0.87 DRD2 (0.70) DRD2DRD3HTR1AHTR7DRD4
SCHEMBL8085463 0.84 DRD2 (0.67) DRD2DRD3HTR1AHTR7DRD4
Hydrochloric Acid SCHEMBL8091842 0.84 DRD2 (0.66) DRD2DRD3HTR1AHTR7DRD4
SCHEMBL8078634 0.83 DRD2 (0.77) DRD2DRD3HTR1AHTR7DRD4
SCHEMBL8091851 0.82 DRD2 (0.78) DRD2DRD3HTR1AHTR7DRD4
SCHEMBL8086604 0.81 DRD2 (0.61) DRD2DRD3HRH3ADRA1AALDH1A1
SCHEMBL8085595 0.80 DRD2 (0.73) DRD2DRD3HTR1AHTR7DRD4
Hydrochloric Acid SCHEMBL8078633 0.80 DRD2 (0.61) DRD2DRD3HRH3ADRA1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103724-A EXHIBIT MAINLY ANTIPSYCHOTIC EFFECTS, E.G., SCHIZOPHRENIA, ORGANIC MENTAL DISORDERS, AFFECTIVE DISORDERS, ANXIETY, PERSONALITY DISORDERS; NEUROLEPTIC ACTIVITIY; ATYPICAL ANTIPSYCHOTICS, COGNITION ACTIVATORS, ANTIDEPRESSANTS; RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2000-08-15 US disclosed